stockrowLeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- −14.3%
- Free cash flow
- −25.8%
- Total debt
- +0.53%
Quarter to September 2026, against a year earlier
Follow LMAT
Alert me
LeMaitre Vascular, Inc. (LMAT) Return on assets
LeMaitre Vascular, Inc.'s return on assets over the twelve months to 30 September 2026 was 10.1%, up 0.2 percentage points from fiscal 2025 (9.89%). Over the past ten years it has ranged from 6.84% (fiscal 2022) to 16.4% (fiscal 2018); the current reading is higher than 64% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 9.89% | 0.09 |
| FY2024 | 9.80% | 0.64 |
| FY2023 | 9.16% | 2.32 |
| FY2022 | 6.84% | (3.02) |
| FY2021 | 9.86% | 0.24 |
| FY2020 | 9.62% | (0.89) |
| FY2019 | 10.5% | (5.91) |
| FY2018 | 16.4% | 1.37 |
| FY2017 | 15.1% | 4.05 |
| FY2016 | 11.0% | 1.99 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| LMAT LeMaitre Vascular, Inc. | 10.1% |
| STVN Stevanato Group S.p.A. compare | 5.50% |
| ATRC AtriCure, Inc. compare | 2.20% |
| WRBY Warby Parker Inc. compare | 1.00% |
| STAA STAAR Surgical Company compare | 0.11% |
| XRAY DENTSPLY SIRONA Inc. compare | −2.23% |
| AZTA Azenta, Inc. compare | −6.31% |
| KMTS Kestra Medical Technologies, Ltd. compare | −48.9% |
| PLSE Pulse Biosciences, Inc compare | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on LMAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement